1. 49-72 of 174 « 1 2 3 4 5 6 7 8 »
    1. The Battle For Bristol-Myers Begins

      The Battle For Bristol-Myers Begins

      BMY has fallen on hard times of late, one of the weakest performers in healthcare. However, activist JANA Partners is quietly lurking. What will be the catalyst for JANA to finally get more involved? Bristol-Myers (NYSE: BMY ) has activist investor Barry Rosenstein and his JANA Partners as a shareholder. JANA hasn't announced any plans, or even considered the stake activist. Still, JANA could be playing wait-and-see...

      Read Full Article
      Mentions: stock options
    2. Johnson & Johnson: Too Big To Break Up

      Johnson & Johnson: Too Big To Break Up

      Johnson & Johnson is at a $317 billion market cap. Which means it might be too big to grow, having underperformed for years. The only question is will a major activist step up or will JNJ become its own activist? It appears that it wil take a major activist to shake things up at the $300 billion-plus market cap healthcare giant Johnson & Johnson (NYSE: JNJ ).

      Read Full Article
    3. Twitter: New CEO, Finally?

      Twitter: New CEO, Finally?

      If high levels of insider selling is bad, what about high levels of insider resigning? Jack Dorsey continues to consolidate his power as CEO to run Twitter as a glorified chatroom. Twitter needs a new CEO, otherwise it’s a $12 stock. Again, Twitter (NYSE: TWTR ) needs a new CEO. As I've noted , ideally, Jack steps down (or gets fired - more likely) from TWTR in 2017 and runs Square (NYSE: SQ ) full-time. By all accounts, there's no buyout coming. But who can oust Jack Dorsey?

      Read Full Article
      Mentions: CEO Chairman
    4. Yahoo And Verizon: Either Way, It's Yahoo Shareholders That Lose

      Yahoo And Verizon: Either Way, It's Yahoo Shareholders That Lose

      Yahoo and Verizon continue to jockey for position with one another after the latest data breach revelations. Sell side analysts seem to think the deal will go through, but at a lower price. We're slightly more skeptical. No matter what the outcome, Yahoo shareholders remain the losers and this entire ordeal is a great reminder of why not to own Yahoo stock now, or going forward...

      Read Full Article
      Mentions: Management Chairman
    5. Goldman Sachs Has A Lot Of Worries In 2017

      Goldman Sachs Has A Lot Of Worries In 2017

      President-elect Donald Trump's promised rollback of stiffer banking-industry rules implemented after the financial crisis eight years ago could easily get bogged down in regulatory agencies or Congress. European officials may erect competitive barriers that might protect the region's weakened banks from market-share intrusions by U.S. investment banks...

      Read Full Article
      Mentions: Dodd-Frank
    6. Wells Fargo & Co. - It Will Take A While To Restore

      Wells Fargo & Co. - It Will Take A While To Restore

      The pace of new consumer checking account openings continued to weaken since the company's September 8th announcement with October account openings down 27% from September and down 44% year-over-year. Balances remain fairly flat across deposit accounts (period end deposits for consumer and small business customers down 1% month-to-month but up 7% YoY) and existing customers...

      Read Full Article
    7. Don't Believe The Hype: Why It Makes No Sense For Buffett To Buy This Food Giant

      Don't Believe The Hype: Why It Makes No Sense For Buffett To Buy This Food Giant

      With Berkshire Hathaway sitting on $85 billion in cash the street is abuzz over rumors of the Oracle of Omaha's next big acquisition. Currently, investors are betting that Mondelez is the takeover target of Kraft Heinz. However, when while such a deal might make sense from a superficial level, when you actually look at the math, it just doesn't make sense...

      Read Full Article
    8. Praxair, Linde close in on deal

      Praxair, Linde close in on deal

      Praxair, Linde close in on deal Dec. 19, 2016 3:29 AM ET | About: Linde AG ADR (LNEGY) | By: Yoel Minkoff , SA News Editor According to various media reports, an agreement on their $65B merger could be announced as early as Wednesday. Initial discussions collapsed in September due to disputes over personnel, headquarters and other details, but Linde ( OTCPK:LNEGY ) is said to have revived talks after Praxair (NYSE: PX ) provided new assurances over jobs and corporate governance.

      Read Full Article
    9. Activist Twinleaf Targets Truett-Hurst

      Activist Twinleaf Targets Truett-Hurst

      Twinleaf Management LLC will have a discussion with Truett-Hurst to return value to the shareholders. Alon Brav from Duke University explains that this activist process returns approximately 7%. The activist will work on the capital allocation and the current expenses of the company. A few changes may make the stock price recover. Introduction Truett-Hurst, Inc. (NASDAQ: THST ) was recently targeted by Twinleaf Management LLC...

      Read Full Article
    10. Starboard's Jeff Smith Likely To Get Depomed Sold

      Starboard's Jeff Smith Likely To Get Depomed Sold

      Activist investor Jeff Smith of Starboard managed to insert 3 people on Depomed’s board. From his track record, he is likely trying to sell the company and make some money off of it quick. Depomed doesn’t want to sell, and is making itself unattractive with pessimistic guidance, despite the nucynta win that makes the company more valuable...

      Read Full Article
    11. Twitter: The Activist Investor Within

      Twitter: The Activist Investor Within

      There’s no doubt that TWTR has been yearning for an activist for months. However, it might have to settle for something a bit different. Can CEO @jack become the activist we all need? Shares of Twitter (NYSE: TWTR ) are kicking around $18 a share and are well off the $25 we saw at the height of the buyout talk. Still, TWTR is trading at 5x sales, which is more like a "growth" or social media story. Yet, TWTR is much more of a media company...

      Read Full Article
      Mentions: Management CEO
    12. Companies that Regularly Raise their Dividend Payments

      Companies that Regularly Raise their Dividend Payments

      Companies that regularly raise their dividend payments show confidence in future earnings growth potential. I monitor dividend increases for stocks on my watch list of dividend growth stocks to identify candidates for further analysis. This past week, 9 companies on my watch list decided to increase their dividends, including one of the stocks I own...

      Read Full Article
    13. Why We Wouldn't Invest In Chipotle Just Because Of Ackman's Confidentiality Agreement

      Why We Wouldn't Invest In Chipotle Just Because Of Ackman's Confidentiality Agreement

      Activist investor Ackman signs confidentiality agreement with CMG just days after it is reported that company has hired a law firm to fend him off. We think Ackman wants to swap out some Board Members and that he may not have any additional groundbreaking plans aside from a simple turnaround of the business. Ackman knows quick serve restaurants well, but valuation would still keep us away from CMG here ...

      Read Full Article
    14. Gilead Sciences: Activist Investor Wanted

      Gilead Sciences: Activist Investor Wanted

      After Q3, Gilead has $31.6B cash on hand. The company also has substantial debt and quarterly interest payments increased to $242M in Q3. Despite shares approaching a 3-year low, the buyback slows down. Gilead Sciences' (NASDAQ: GILD ) Q3 results came in more or less as expected, and shares did neither rise nor drop. This leaves a year-to-date loss of 28% while the stock continues trading in the lower seventies...

      Read Full Article
    15. Chipotle Has A Credibility Problem And Ackman Isn't Helping Right Now

      Chipotle Has A Credibility Problem And Ackman Isn't Helping Right Now

      CMG misses on almost every data point yesterday. Guidance is the only thing that has prevented a full out stock crash, we believe. We're not sure guidance should be trusted, we think management has lack of visibility into the business. By Parke Shall While Chipotle's (NYSE: CMG ) quarterly earnings came out and disappointed many investors, the company offered guidance that was relatively optimistic sounding...

      Read Full Article
    16. Mylan Now Likely An Acquisition Target With 100% Upside Possible

      Mylan Now Likely An Acquisition Target With 100% Upside Possible

      Mylan remains significantly undervalued. Post-DOJ settlement, the stock should be back near $50. Instead, it trades at $36 due to inefficient analysis of the company's situation by the market. We now believe long term 100% upside is possible given the company's reiteration of $6 EPS in 2018. By Parke Shall We honestly wouldn't be surprised if we saw somebody come in and make a bid for Mylan (NASDAQ: MYL ) at this stage in the game...

      Read Full Article
    17. Should Mylan's Shareholders Hang On Following Government Settlement?

      Should Mylan's Shareholders Hang On Following Government Settlement?

      Enlight Research Summary Mylan's common stock has soared from $35.94 per share at closing on 10-7-2016 to $40.40 at the opening bell on 10-10-2016 following a $465 million settlement with the U.S. government. Although Mylan’s total returns were significantly above their peers’ returns from August 2013 until October 2015, Mylan’s performance has lagged behind that of its peers since May of 2016...

      Read Full Article
    18. Viacom Plus CBS May Equal Not Much

      Viacom Plus CBS May Equal Not Much

      Summary Viacom appears to want a merger between it and CBS. A bigger company offers a bigger collection of platforms, and it may make the job of executives seeking overall shareholder value expansion easier. There are many risks to such a strategy: CBS is a different beast, the skills of Leslie Moonves may not translate over to the Viacom side of the equation...

      Read Full Article
      Mentions: CEO stock options
    49-72 of 174 « 1 2 3 4 5 6 7 8 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content